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T
he past decade has seen 
the establishment of the 
systematic review (SR) as one 
of the cornerstones of evidence-
based medicine. The value of SRs to 
researchers, practitioners, and policy 
makers is well established; when done 
well, they are considered the highest 
level of evidence for medical decision 
making. Potentially, they are also a 
resource for patients seeking to make 
sense of the relative value of different 
treatments. 
It is important to distinguish SRs from 
the traditional, narrative reviews also 
often published in medical journals. 
A helpful deﬁ  nition of a SR, which 
also clariﬁ  es the difference between 
an SR and meta-analysis, comes from 
the Web site (http://www.cochrane.
org/resources/glossary.htm) of the 
Cochrane Collaboration (named 
after Archie Cochrane, a British 
medical researcher), an international 
organization that publishes rigorous 
SRs evaluating the effectiveness of a 
wide range of health care interventions. 
Their deﬁ  nition of a SR is this: “A review 
of a clearly formulated question that 
uses systematic and explicit methods to 
identify, select, and critically appraise 
relevant research, and to collect and 
analyze data from the studies that 
are included in the review. Statistical 
methods (meta-analysis) may or may not 
be used to analyze and summarize the 
results of the included studies.”
The increasing number of new 
SRs being published (currently 
estimated as being around 2,500 per 
year [1]) have become an essential 
part of the biomedical literature. But 
SRs that are of low quality or out of 
date have the potential to mislead, 
and selective publication of SRs that 
support particular agendas—or failure 
to publish those with “undesirable” 
results—could undermine the 
literature’s reliability in the same way 
that biased publication of primary 
research can. How rigorously are 
these reviews being performed? How 
consistent are they in reporting their 
methods and their results?
In this issue we publish an article [1] 
by David Moher and colleagues that 
examines both the “epidemiological 
aspects” of published SRs and their 
“reporting characteristics.” It is not 
the ﬁ  rst time SR quality has been 
examined, but this study is different in 
that it does not focus on a particular 
area of health care, one type of 
intervention, or a sample of journals, 
but on all SRs indexed on PubMed 
within a speciﬁ  ed period of time—one 
month, November 2004. The authors 
included both SRs published in the 
Cochrane Database of Systematic 
Reviews (CDSR) and those published 
elsewhere. Although such a limited 
period can only be a snapshot, this 
detailed assessment of 300 reviews 
revealed several points of interest. 
There were clear differences in the 
quality of reporting between Cochrane 
and non-Cochrane SRs. Many reviews 
included no mention of a pre-speciﬁ  ed 
protocol by which the review was 
conducted. Although a protocol is 
required of all Cochrane reviews, only 
11% of non-Cochrane reviews had 
one. This lack of a protocol—which 
delineates the search strategy, inclusion 
criteria, and the plan for the analysis 
that will be conducted—naturally leads 
to concerns about methodological rigor 
in the assessment of the study question. 
It is Cochrane policy that published 
reviews should be regularly updated. 
One-third of the CDSR reviews in 
Moher’s sample were in fact updates. 
However, updating is uncommon 
elsewhere; in the Moher sample, 
only 2% of non-Cochrane reviews 
were updates. Related to this issue is 
the observation that outside of the 
Cochrane Collaboration none of the 
reviews were registered with a central 
body. Hence, it would be hard to locate 
and access updates even if they were 
done. 
The quality of reporting in many 
of the SRs was disappointing. Despite 
the guidelines of the Cochrane 
Collaboration and the QUOROM 
(Quality of Reporting of Meta-
Analyses) initiative [2], important 
items were frequently missing, again 
mostly from non-Cochrane reviews. For 
example, only two-thirds of all reviews 
mentioned the years searched; an equal 
number gave information on quality 
assessment of studies included, and 
fewer than a quarter gave an indication 
of having assessed for publication bias. 
There was a lack of detail regarding 
eligibility criteria; many reviews did 
not make clear whether they were 
restricted by study type or whether 
data came only from published studies. 
Only three-quarters of the reviews dealt 
with potential harms (in addition to 
beneﬁ  ts) of the intervention under 
review.
Perhaps of most concern, the authors 
noted: “Strong evidence of outcome 
reporting bias was recently reported 
within clinical trials. Our results suggest 
that some aspect of selective outcome 
reporting bias might also exist within 
non-Cochrane reviews. Only about one-
quarter of them reported a primary 
outcome, of which half report statistical 
signiﬁ  cance in favour of this outcome 
(versus 14.4% for Cochrane reviews).”
Collectively, given the importance 
accorded to SRs, these ﬁ  ndings are 
worrying. While length limitations 
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imposed by most journals (but not by 
CDSR) may contribute to incomplete 
reporting, it seems more likely that 
many authors are not fully aware of the 
tools that are available to help them 
report SRs. Reporting all the items 
on the QUOROM checklist is neither 
onerous nor excessively lengthy; 
unfortunately many journals, especially 
the smaller subspecialty journals in 
which many SRs are published, have 
yet to adopt these reporting guidelines. 
For example, as Moher and colleagues 
point out, less than 7% overall (and, 
surprisingly, only 4% of Cochrane 
reviews) used a QUOROM ﬂ  owchart 
to illustrate the stages of doing the 
systematic review.
PLoS is committed to publishing 
high-quality systematic reviews, and 
the online format of our journals 
allows ﬂ  exibility in the length of the 
research articles we publish. However, 
the number of research articles that 
PLoS Medicine can accept is limited, so 
we are not able to publish every well-
conducted SR that comes our way. We 
will restrict ourselves to publishing 
those that we believe have ﬁ  ndings 
that represent an important advance 
that will interest our general medical 
audience. 
PLoS’s new journal, PLoS ONE is, 
however, able to publish many more 
papers than PLoS Medicine can. PLoS 
ONE is committed to publishing any 
SR that is conducted, described, and 
interpreted well, and it welcomes 
the submission of SRs across all 
areas of health care. Moreover, PLoS 
ONE can also publish updates of 
SRs, provided that the update itself 
contains sufﬁ  cient detail for a reader 
who cannot access the original report 
to understand what was done. If the 
original report is freely available, the 
update can be linked electronically to 
the original publication. We require 
that that all SRs submitted to us 
include a protocol and QUOROM 
checklist (or any updated version 
of this checklist) submitted as 
supplementary ﬁ  les. These items will 
be made available to peer reviewers, 
and published with the paper. In 
order to help authors report SRs 
systematically, we now also provide 
an optional template that follows the 
current QUOROM checklist. This 
template will be updated as needed in 
future.
But no one journal or publisher 
can single-handedly address the issues 
involved here. Moher and colleagues 
call for the registration of SRs in the 
same manner as is now required for 
clinical trials: it would then, at least, 
be possible to track those that are 
performed. This is an interesting 
proposal, and would certainly help in 
the linking of SRs to updates. We would 
welcome opinions on this proposal.
Despite the best efforts of the 
Cochrane Collaboration and the 
QUOROM group, there is still a 
long way to go before readers can 
assume that all SRs are conducted and 
reported in a way that reliably provides 
an accurate synthesis of the evidence 
available. 
The QUOROM group is responding 
to this situation. The group met toward 
the end of 2006 and has made major 
revisions to its guidelines. Additionally, 
to facilitate a better understanding and 
dissemination of the guidelines, the 
group has embarked on developing 
an explanation and elaboration 
document similar to that used to 
create the corresponding CONSORT 
(Consolidated Standards of Reporting 
Trials; for reporting of clinical trials) 
and STARD (Standards for Reporting 
of Diagnostic Accuracy; for reporting 
of diagnostic studies) documents. It is 
anticipated that both documents will be 
submitted for publication consideration 
around the middle of this year. The 
group will also be changing its name 
from the much misspelled “QUOROM” 
to PRISMA (Preferred Reporting 
Items for Systematic Reviews and Meta-
Analyses). 
We hope these developments 
will go some way to maximizing the 
dependability of systematic reviews 
and justifying their position as the gold 
standard of evidence in health care.  
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